Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Ongoing drug recalls - open right now

Every FDA drug recall whose status is still Ongoing: the firm is still removing product from the market, or the FDA has not yet closed the file. Some were opened years ago and never formally terminated, so check the initiation date as well as the status.

2,760 recalls, newest first.

Class II · Moderate risk

Azelaic Acid Gel

CGMP Deviations: Market complaints received for gritty texture (grainy)

Ongoing cGMP deviation Glenmark Pharmaceuticals Inc., USA NDC 68462-626-52 D-0662-2025
Class II · Moderate risk

Levothyroxine Sodium Tablets

Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.

Ongoing Wrong potency / content Accord Healthcare, INC. NDC 16729-450-15 D-0006-2026
Class II · Moderate risk

edunn clarity

Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.

Ongoing Chemical / undeclared Private Label Skin Care Inc. D-0668-2025
Class II · Moderate risk

Micronized BPO Gel Cleanser 10%

Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.

Ongoing Chemical / undeclared Private Label Skin Care Inc. D-0667-2025
Class II · Moderate risk

mel rx Skin

Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.

Ongoing Chemical / undeclared Private Label Skin Care Inc. D-0666-2025
Class II · Moderate risk

Skin MD by Dr Monika Kiripolsky

Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.

Ongoing Chemical / undeclared Private Label Skin Care Inc. D-0664-2025
Class II · Moderate risk

Artisan of Skin

Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.

Ongoing Chemical / undeclared Private Label Skin Care Inc. D-0663-2025
Class III · Low risk

Espumil

Labeling: Not Elsewhere Classified

Ongoing Labeling / mix-up Letco Medical LLC D-0138-2026
Class II · Moderate risk

Major ChlorproMAZINE Hydrochloride Tablets

CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit

Ongoing Nitrosamine impurity The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-7133-61 D-0013-2026
Class II · Moderate risk

Major ChlorproMAZINE Hydrochloride Tablets

CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit

Ongoing Nitrosamine impurity The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-7132-61 D-0012-2026
Class II · Moderate risk

Major ChlorproMAZINE Hydrochloride Tablets

CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit

Ongoing Nitrosamine impurity The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-7131-61 D-0011-2026
Class II · Moderate risk

Major ChlorproMAZINE Hydrochloride Tablets

CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit

Ongoing Nitrosamine impurity The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-7130-61 D-0010-2026
Class II · Moderate risk

Major ChlorproMAZINE Hydrochloride Tablets

CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit

Ongoing Nitrosamine impurity The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-7130-06 D-0009-2026

Recalls by year